Gestational trophoblastic neoplasia natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 15: Line 15:
:* [[Histologic]] type (invasive mole or choriocarcinoma)
:* [[Histologic]] type (invasive mole or choriocarcinoma)
:* Extent of spread of the disease/largest [[tumor]] size
:* Extent of spread of the disease/largest [[tumor]] size
:* Level of serum beta-hCG
:* Level of serum [[beta-hCG]]
:* Duration of disease from the initial [[pregnancy]] event to start of treatment
:* Duration of disease from the initial [[pregnancy]] event to start of treatment
:* Number and specific sites of [[metastasis]]
:* Number and specific sites of [[metastasis]]

Revision as of 15:18, 19 October 2015

Template:Choriocarcinoma Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

Overview

Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good.[1]

Natural history

Prognosis

  • The prognosis for cure of patients with GTDs is good even when the disease has spread to distant organs, especially when only the lungs are involved.[1]
  • The probability of cure depends on the following:
  • Histologic type (invasive mole or choriocarcinoma)
  • Extent of spread of the disease/largest tumor size
  • Level of serum beta-hCG
  • Duration of disease from the initial pregnancy event to start of treatment
  • Number and specific sites of metastasis
  • Nature of antecedent pregnancy
  • Extent of prior treatment

Complications

References

  1. 1.0 1.1 General Information About Gestational Trophoblastic Disease. National Cancer Institute. http://www.cancer.gov/types/gestational-trophoblastic/hp/gtd-treatment-pdq Accessed on October 14, 2015

Template:WH Template:WS